Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients With Juvenile Idiopathic Arthritis

Autor: Josh DeClercq, Amy A Mitchell, Leena Choi, Andrea M Goettel, Thomas B Graham

Publikováno v: J Pediatr Pharmacol Ther

OBJECTIVE The lack of randomized controlled trials comparing biologics for the treatment of juvenile idiopathic arthritis (JIA) has led to wide variation in treatment approaches. The objective of this study is to compare the efficacy and safety of ab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b28b9d0ba823972adaf91b317240f3e8
https://doi.org/10.5863/1551-6776-26.2.157

Race, Income, and Disease Outcomes in Juvenile Dermatomyositis

Autor: Thomas B. Graham, Lisa Imundo, Steven J. Spalding, Kathleen M. O'Neil, Mara L. Becker, Marilynn Punaro, Joyce J. Hsu, Heather Benham, Beth Gottlieb, Kenneth N. Schikler, Jennifer M. P. Woo, Mary Ellen Riordan, Angela Byun Robinson, Sivia K. Lapidus, Daniel J. Kingsbury, Deborah McCurdy, Pamela F. Weiss, Jenna Tress, Nora G. Singer, Kathryn S. Torok, Deborah Rothman, Jennifer E. Weiss, Karen Onel, Brian M. Feldman, J. R. Hollister, Richard K. Vehe, Gloria C. Higgins, Anna Huttenlocher, Hilary M. Haftel, Thomas A. Griffin, Thomas J. A. Lehman, Donald P. Goldsmith, Polly I. Ferguson, Eyal Muscal, Joni Dean, Sampath Prahalad, Leslie Abramson, Eleanor S. Anderson, Mark F. Hoeltzel, Philip Kahn, Hermine I. Brunner, Reema H. Syed, Ali Yalcindag, Kristin E. Klein, Judyann C. Olson, C. Egla Rabinovich, Carol B. Lindsley, Marisa S. Klein-Gitelman, Natasha M. Ruth, Norman T. Ilowite, Fatma Dedeoglu, Timothy Beukelman, Lydia M. Walters, Lawrence S. Zemel, Andrew J. White, Peter R. Blier, Sarah Ringold, Susan Kim, Emily von Scheven, Rita S. Jerath, Ann M. Reed, Kathryn Phillippi, Lawrence Jung, Michael A. Malloy

Publikováno v: The Journal of pediatrics. 184

To determine the relationships among race, income, and disease outcomes in children with juvenile dermatomyositis (JDM).Data from 438 subjects with JDM enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d86558e886dac3d1a7a82db1886eee
https://pubmed.ncbi.nlm.nih.gov/28434566

A review of biobehavioral research in juvenile primary fibromyalgia syndrome

Autor: Thomas B. Graham, Michelle D. Huenefeld, Susmita Kashikar-Zuck, Scott W. Powers

Publikováno v: Arthritis & Rheumatism. 13:388-397

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a055a8841302a95e5c3138def96fd6cc
https://doi.org/10.1002/1529-0131(200012)13:6<388::aid-art9>3.0.co

Depression, coping, and functional disability in juvenile primary fibromyalgia syndrome

Autor: Kenneth R. Goldschneider, Thomas B. Graham, Jonathan C. Miller, Susmita Kashikar-Zuck, Michelle H. Vaught

Publikováno v: The journal of pain. 3(5)

This study describes pain characteristics, coping, depression, and functional disability in children with juvenile primary fibromyalgia syndrome (JPFS) and compares them with a group of children with nonmalignant chronic back pain (CBP). Subjects wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5da738df1579647464a84e180ebf685
https://pubmed.ncbi.nlm.nih.gov/14622745

[Untitled]

Autor: Murray H. Passo, Susan Lee, Joyce Villanueva, Alexandra H. Filipovich, Edward H. Giannini, Thomas B. Graham, Alexei A. Grom

Publikováno v: Arthritis Research & Therapy. 7:R30

Macrophage activation syndrome (MAS) has been reported in association with many rheumatic diseases, most commonly in systemic juvenile rheumatoid arthritis (sJRA). Clinically, MAS is similar to hemophagocytic lymphohistiocytosis (HLH), a genetic diso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4ba0fe0d4a210536d90627c2b108600d
https://doi.org/10.1186/ar1453